Scientific Advisory Board
Last updated on 15 May 2025
Remit
The Scientific Advisory Board gives its opinion on the major orientations of our agency’s scientific strategy and on its activities. It also provides a forward-looking approach and reports on the work undertaken. This body helps to coordinate the efforts of its members in preparing for and responding to crises linked to emerging diseases, at scientific, industrial and public action levels.
It brings together 21 French and international scientific figures, as well as 3 representatives from the voluntary sector. Members are appointed for a four-year term by the Advisory Board on the recommendation of the agency Director.
Chair
Prof. Sharon Lewin
University of Melbourne, The Doherty Institute, Australia
Fabien Zoulim
Hospices Civils de Lyon, UMR Inserm – Université Claude Bernard Lyon 1 U1350 PaThLiv, Lyon Hepatology Institute, France
Members
Dissou Affolabi
(Abomey-Calavi University, Cotonou, Benin)
Yvanie Caillé
(Association RENALOO, Paris, France )
Jeremiah Chakaya
(Kenyatta University, Nairobi, Kenya)
Dominique Costagliola
(Académie des Sciences, Directrice de Recherche émérite, Institut Pierre Louis d’épidémiologie et de santé publique, Paris, France)
Maura Dandri
(University Medical Center, Hamburg-Eppendorf, Hamburg, Germany)
Virginie Deret
(SOS Hépatites, France )
Meg Doherty
(WHO, Geneva, Switzerland)
Daniel Douek
(Vaccine Research Center, NIAID/NIH, Bethesda, USA)
Seng Gee Lim
(National University Health System, Singapore)
Peter Horby
(Pandemic Sciences Centre, ISARIC, UK )
Brad Jones
(Weill Cornell Medical College, New-York, USA)
Oanh Khuat
(Center for Support Community Development Initiatives, Hanoï, Vietnam)
Marion Koopmans
(Erasmus MC, Rotterdam, Netherlands )
Karine Lacombe
(Hopital Saint Antoine, Paris, France)
Graeme Meinttjes
(University of Cape Town, South Africa)
Jennifer Price
(University of California San Francisco USCF Health, USA)
Nina Russell
(Gates Fundation, Seattle, USA)
Ester Sabiano
(Universidade de São Paulo, Brazil)
Olivier Schwartz
(Institut Pasteur, Paris, France)
Rodolphe Thiébaut
(Bordeaux Population Health – Inserm Unit 1219, CHU de Bordeaux, Université de Bordeaux, France )
Lucas Vallet
(Collectif TRT5-CHV, Paris, France)
Scott Weaver
(University of Texas Medical Branch, Galveston National Laboratory, USA )